slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 24,541-24,570
Pages 1,371
Rows per page 30
Component
24,541-24,570 of 41,127
30
Standard corporate 'at-a-glance' summary slide.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
31
The slide uses a grid of icons and metrics to present company fundamentals and market size.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
32
Includes disclaimer about non-retouched photos and medical source credits.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
33
Bausch Health Companies | Results Presentation Deck | 91 slidesBausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
34
Bausch Health Companies | Results Presentation Deck | 91 slidesBausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
36
The slide details the financial impact of segment realignments, showing reported vs. restated figures.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
44
Includes non-GAAP metrics and segment-specific performance data.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
46
The slide highlights a 1% organic revenue decline for the segment.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
47
Includes segment-specific revenue and operating expense breakdown.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
48
The slide includes a specific callout for the revenue decline of the WELLBUTRIN/APLENZIN product line.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
52
Includes non-GAAP metrics like EBITA and organic growth.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
63
The table reconciles GAAP net income to non-GAAP adjusted net income, detailing specific adjustments like amortization, impairments, and restructuring costs.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
67
The table provides supplemental financial metrics for Bausch Pharma, likely for valuation or modeling purposes.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
71
The table provides a detailed breakdown of financial metrics for the Diversified Products segment, including specific revenue streams (Neuro & Other, Generics, Dentistry).Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
72
The slide provides a detailed breakdown of non-GAAP adjustments including amortization, asset impairments, restructuring, and other one-time costs.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
73
The slide provides a detailed breakdown of non-GAAP adjustments including amortization, impairments, and restructuring costs.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
74
Contains footnotes 1-5 explaining segment reporting and asset impairment details.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
77
The table provides a clear breakdown of adjustments including taxes, D&A, asset impairments, acquisition costs, and share-based compensation.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
78
Includes adjustments for foreign exchange rates, divestitures, and discontinuations.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
79
The table breaks down revenue adjustments by segment, including foreign exchange impacts and divestitures/discontinuations.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
80
The table is split into two main sections: calculation of organic revenue for current periods and calculation of organic revenue for prior periods, followed by a growth comparison.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
81
The table adjusts reported revenue for exchange rates and divestitures/discontinuations to arrive at organic revenue.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
02
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Attention1 hit
07
The slide uses a hub-and-spoke style diagram to show how integrated capabilities feed into the pipeline.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
25
Slide 25 of a BioNTech presentation.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
32
The table shows a significant increase in commercial revenues and profit for 2021 compared to 2020.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
33
The chart breaks down revenue into four categories, with COVID-19 vaccine revenues being the primary driver.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
02
Blue Apron | Results Presentation Deck | 18 slidesBlue Apron | Results Presentation Deck | 18 slides · Blue Apron
Conference presentation Investor relations 1 hit
02
Page number 2 indicated at bottom right.Boxed | SPAC Presentation Deck | 53 slides · Boxed
Pitch deck Investment bank 1 hit
37
Includes detailed footnotes regarding share vesting, debt terms, and calculation methodology.Boxed | SPAC Presentation Deck | 53 slides · Boxed
Pitch deck Investment bank 1 hit